Maj. Matthew Golsteyn in Afghanistan. (Photo courtesy of Philip Stackhouse.)

Army Special Forces Maj. Matthew Golsteyn – whom President Donald Trump has called "a U.S. Military hero" – will face an Article 32 hearing in March after being charged with murder for allegedly killing a suspected Taliban bomb-maker.

On Dec. 18, the convening authority for Golestyn's case decided to hold the preliminary hearing in connection with the Feb. 28, 2010 incident, Army officials have announced. The proceedings are slated to start on March 14 at Fort Bragg, North Carolina.

Read More Show Less

WASHINGTON (Reuters) - The U.S. Supreme Court on Monday turned away a bid by U.S. troops sickened by smoke from open-air pits used to burn waste in Iraq and Afghanistan to revive a lawsuit against defense contractors KBR Inc and Halliburton Co.

Read More Show Less

KABUL (Reuters) - Afghan Chief Executive Abdullah Abdullah said on Wednesday that the Taliban's refusal to involve the government in peace talks means the end to a conflict that has lasted 17 years can only remain a dream.

Read More Show Less

PESHAWAR, Pakistan (Reuters) - The Afghan Taliban said on Tuesday they had called off peace talks with U.S. officials in Qatar this week due to an "agenda disagreement," especially over the involvement of Afghan officials as well as a possible ceasefire and prisoner exchange.

Read More Show Less
Courtesy of retired Marine Maj. Fred Galvin.

A Marine officer who was fired after false rumors that his special operations unit massacred Afghan civilians has been vindicated.

The Board for Corrections of Naval Records recently removed two adverse fitness reports from retired Maj. Fred Galvin's record: The first one came as a result of a March 2007 incident, during which he led Marine Special Operations Company Foxtrot in Afghanistan; the second came after he was relieved in 2011 for questioning a lieutenant colonel in Afghanistan who allegedly said he was "willing to sacrifice the lives" of Marines under his command.

Read More Show Less
© 2018 Hirepurpose. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service.